Autopsy report · NCT04026997
A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
Cause of deathFunding or business, also drug or device supply
“Terminated based on Sponsor decision due to lot recall of GEBT kits impacting the primary endpoint evaluation for Dose 2 and Dose 3.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 1 year 3 months before it stopped.
- 72 participants enrolled.
- Results were posted on the registry 5 years 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- CinDome Pharma, Inc.
- Sponsor type
- Industry
- Conditions
- Gastroparesis
- Interventions
- CIN-102 Dose 1; CIN-102 Dose 2; CIN-102 Dose 3; Placebo
- Participants
- 72
- Sites
- 19
- Countries
- United States
Trials that died the same way
- Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
“Terminated by sponsor - Single dose safety objective achieved.” - Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas
“Study was terminated at completion of the Phase 1 dose escalation due to loss of financial support.” - A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
“The Sponsor terminated the study due to early dose-limiting toxicities.” - Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors
“Study was terminated by sponsor after Phase 1b as pre-defined signals of efficacy were not met in the Phase 1b dose expansion cohort.” - Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients
“The study has been prematurely terminated due to the onset of 2 dose limiting toxicities in 2 patients.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.